TI - Serum Soluble Programme Death-1 and Programme Death- Ligand 1 Identify Multiple Myeloma Patients: Serum sPDL-1 May Be a Prognostic Marker
PT - Journal Article
DP - 2019
TA - EJMI
PG - 23-31
VI - 3
IP - 1
AID - 2019.17854 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.2019.17854
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2019 3(1): 23